Cardiff Oncology (CRDF) PT Raised to $25 at Maxim Group
Tweet
Share
E-mailGet Alerts CRDF Hot Sheet
Price: $0.90 --0%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Maxim Group analyst Naureen Quibria raised the price target on Cardiff Oncology (NASDAQ: CRDF) to $25.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
- Mizuho Financial Group (8411:JP) (MFG) PT Raised to JPY10,760 at JPMorgan
- IPCA Laboratories (IPCA:IN) PT Raised to INR2,060 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
